SPONSOR
Anhui Provincial Hospital
Total Trials
11
Recruiting
11
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2, Phase 1
Conditions studied: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)Prostate CancerHepatocellular CarcinomaAdvanced Solid TumorsFeverChest TightnessEsophageal Squamous Cell CarcinomaLiver MetastasesMetastases to LiverLiver Cancer
Anhui Provincial Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD), Prostate Cancer, Hepatocellular Carcinoma, Advanced Solid Tumors.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Anhui Provincial Hospital
How many clinical trials has Anhui Provincial Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Anhui Provincial Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD), Prostate Cancer, Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Anhui Provincial Hospital research focus on?
Anhui Provincial Hospital clinical trials span Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD), Prostate Cancer, Hepatocellular Carcinoma, Advanced Solid Tumors, Fever, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Anhui Provincial Hospital clinical trial?
To participate in a Anhui Provincial Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Anhui Provincial Hospital trials with current recruitment status updated daily.
Clinical Trials by Anhui Provincial Hospital
NCT06321198
Recruiting
A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
NCT06737588
Recruiting
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
Prostate Cancer
NCT06498622 Phase 2
Recruiting
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
Hepatocellular Carcinoma
NCT07106814 EARLY_Phase 1
Recruiting
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Advanced Solid Tumors
NCT05940415
Recruiting
Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer
Prostate Cancer
NCT07231770
Recruiting
Sulfamethoxazole Prophylaxis Duration After Renal Transplantation
Fever
NCT07188103 Phase 2
Recruiting
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT07602504
Recruiting
China Metastatic Liver Cancer Clinical Registry Cohort Database
Liver Metastases
NCT06527898 Phase 1, Phase 2
Recruiting
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Small-cell Lung Cancer
NCT06558253 Phase 1
Recruiting
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
Hematopoietic Recovery
NCT06405945
Recruiting
Cervical Cancer Susceptible Population Classification
Cervical Cancer Susceptible Population Classification
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology